Incomplete penetrance and variable expressivity: Is there a microRNA connection?

BioEssays

Volumn 31, Issue 9, 2009, Pages 981-992

  Ahluwalia, Jasmine K ^a,b   Hariharan, Manoj ^b   Bargaje, Rhishikesh ^b   Pillai, Beena ^b   Brahmachari, Vani ^a  

^a UNIVERSITY OF DELHI   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Epigenetics; Incomplete penetrance; MicroRNA; Modifier; Variable expressivity

Indexed keywords

HETEROCHROMATIN PROTEIN 1; MICRORNA; POLYCOMB GROUP PROTEIN;

3' UNTRANSLATED REGION; ALLELE; DNA METHYLATION; DNA MODIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETIC VARIABILITY; GENOME IMPRINTING; HAPPY PUPPET SYNDROME; HUMAN; INCOMPLETE PENETRANCE AND VARIABLE EXPRESSIVITY; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE BINDING SITE; PENETRANCE; PRADER WILLI SYNDROME; PROTEIN RNA BINDING; REVIEW; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

ALLELES; ANIMALS; GENE EXPRESSION; HUMANS; MICRORNAS; PENETRANCE; POLYMORPHISM, GENETIC;

EID: 70349970694     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.200900066     Document Type: Review

References (77)

1. Heyningen, V. V. and Yeyati, P. L., Mechanisms of non-Mendelian inheritance in genetic disease. Hum Mol Genet 2004. 13: R225-R233.
2. Zlotogora, J., Penetrance and expressivity in the molecular age. Genet Med 2003. 5: 347-352.
3. Stern, C., O. Vogt and the terms "Penetrance" and "Expressivity". Am J Hum Genet 1960. 12: 141.
4. Mitchell, M. E., Sander, T. L., Klinkner, D. B. and Tomita-Mitchell, A., The molecular basis of congenital heart disease. Semin Thorac Cardiovasc Surg 2007. 19: 228-237.
5. Accili, D., Kido, Y., Nakae, J., Lauro, D. and Park, B. C., Genetics of type 2 diabetes: insight from targeted mouse mutants. Curr Mol Med 2001. 1: 9-23.
6. Shin, D., Gilbert, F., Goldstein, M. and Schlegel, P. N., Congenital absence of the vas deferens: incomplete penetrance of cystic fibrosis gene mutations. J Urol 1997. 158: 1794-1798.
7. Amiel, J., Sproat-Emison, E., Garcia-Barcelo, M., Lantieri, F., Burzynski, G., et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 2008. 45: 1-14.
8. Di, P. E., Brancaleoni, V., Moriondo, V., Besana, V. and Cappellini, M. D., Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria. Clin Genet 2007. 71: 84-88.
9. Waseem, N. H., Vaclavik, V., Webster, A., Jenkins, S. A., Bird, A. C., et al. Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2007. 48: 1330-1334.
10. Dryja, T. P., Rapaport, J., McGee, T. L., Nork, T. M. and Schwartz, T. L., Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 1993. 52: 1122-1128.
11. Abouzeid, H., Schorderet, D. F., Balmer, A. and Munier, F. L., Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis. Mol Vis 2009. 15: 771-777.
12. Delcuve, G. P., Rastegar, M. and Davie, J. R., Epigenetic control. J Cell Physiol 2009. 219: 243-250.
13. Surani, M. A., Reprogramming of genome function through epigenetic inheritance. Nature 2001. 414: 122-128.
14. Brockdorff, N., X-chromosome inactivation: closing in on proteins that bind Xist RNA. Trends Genet 2002. 18: 352-358.
15. Kohlmaier, A., Savarese, F., Lachner, M., Martens, J., Jenuwein, T. and Wutz, A., A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol 2004. 2: E171.
16. Hark, A. T., Schoenherr, C. J., Katz, D. J., Ingram, R. S., Levorse, J. M., et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000. 405: 486-489.
17. Khosla, S., Aitchison, A., Gregory, R., Allen, N. D. and Feil, R., Parental allele-specific chromatin configuration in a boundary-imprinting-control element upstream of the mouse H19 gene. Mol Cell Biol 1999. 19: 2556-2566
18. Kitsberg, D., Selig, S., Brandeis, M., Simon, I., Keshet, I., et al. Allele-specific replication timing of imprinted gene regions. Nature 1993. 364: 459-463.
19. Gribnau, J., Hochedlinger, K., Hata, K., Li, E. and Jaenisch, R., Asynchronous replication timing of imprinted loci is independent of DNA methylation, but consistent with differential subnuclear localization. Genes Dev 2003. 17: 759-773.
20. Fournier, C., Goto, Y., Ballestar, E., Delaval, K., Hever, A. M., et al. Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J 2002. 21: 6560-6570.
21. Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B. and Cavalli, G., Genome regulation by polycomb and trithorax proteins. Cell 2007. 128: 735-745.
22. Agarwal, N., Hardt, T., Brero, A., Nowak, D., Rothbauer, U., et al. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res 2007. 35: 5402-5408.
23. Garrick, D., Fiering, S., Martin, D. I. and Whitelaw, E., Repeat-induced gene silencing in mammals. Nat Genet 1998. 18: 56-59.
24. Mehta, A. K., Majumdar, S. S., Alam, P., Gulati, N. and Brahmachari, V., Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 2009. 428: 20-24.
25. Fu, Y. H., Kuhl, D. P., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991. 67: 1047-1058.
26. Hagerman, R. J., Hull, C. E., Safanda, J. F., Carpenter, I., Staley, L. W., et al. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 1994. 51: 298-308.
27. Basel-Vanagaite, L., Pelet, A., Steiner, Z., Munnich, A., Rozenbach, Y., et al. Allele dosage-dependent penetrance of RET proto-oncogene in an Israeli-Arab inbred family segregating Hirschsprung disease. Eur J Hum Genet 2007. 15: 242-245.
28. Gouya, L., Puy, H., Robreau, A. M., Bourgeois, M., Lamoril, J., et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 2002. 30: 27-28.
29. Jezequel, P., Dubourg, C., Le, L. D., Odent, S., le Gall, J. Y., et al. Molecular screening of the CFTR gene in men with anomalies of the vas deferens: identification of three novel mutations. Mol Hum Reprod 2000. 6: 1063-1067.
30. Pastinen, T., Sladek, R., Gurd, S., Sammak, A., Ge, B., et al. A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics 2004. 16: 184-193.
31. Cowles, C. R., Hirschhorn, J. N., Altshuler, D. and Lander, E. S., Detection of regulatory variation in mouse genes. Nat Genet 2002. 32: 432-437.
32. Krantz, I. D., Piccoli, D. A. and Spinner, N. B., Clinical and molecular genetics of Alagille syndrome. Curr Opin Pediatr 1999. 11: 558-564.
33. Campos-Xavier, B., Saraiva, J. M., Savarirayan, R., Verloes, A., Feingold, J., et al. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum Genet 2001. 109: 653-658.
34. Caspi, M., Coquelle, F. M., Koifman, C., Levy, T., Arai, H., et al. LIS1 missense mutations: variable phenotypes result from unpredictable alterations in biochemical and cellular properties. J Biol Chem 2003. 278: 38740-38748.
35. Vithana, E. N., bu-Safieh, L., Pelosini, L., Winchester, E., Hornan, D., et al. Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? Invest Ophthalmol Vis Sci 2003. 44: 4204-4209.
36. Imel, E. A., Hui, S. L. and Econs, M. J., FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 2007. 22: 520-526.
37. So, A. Y., Chaivorapol, C., Bolton, E. C., Li, H. and Yamamoto, K. R., Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 2007. 3: e94.
38. Ktistaki, E., Lacorte, J. M., Katrakili, N., Zannis, V. I. and Talianidis, I., Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene. Nucleic Acids Res 1994. 22: 4689-4696.
39. Calkhoven, C. F., Muller, C. and Leutz, A., Translational control of gene expression and disease. Trends Mol Med 2002. 8: 577-583.
40. Surani, M. A., Hayashi, K. and Hajkova, P., Genetic and epigenetic regulators of pluripotency. Cell 2007. 128: 747-762.
41. Shankar, S. P., Fingert, J. H., Carelli, V., Valentino, M. L., King, T. M., et al. Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet 2008. 29: 17-24.
42. Kontorovich, T., Cohen, Y., Nir, U. and Friedman, E., Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers. Breast Cancer Res Treat 2008. 19.
43. Levy-Lahad, E., Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., et al. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 2001. 98: 3232-3236.
44. Bergren, S. K., Chen, S., Galecki, A. and Kearney, J. A., Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. Mamm Genome 2005. 16: 683-690.
45. Owens, S. E., Broman, K. W., Wiltshire, T., Elmore, J. B., Bradley, K. M., et al. Genome-wide linkage identifies novel modifier loci of aganglionosis in the Sox10Dom model of Hirschsprung disease. Hum Mol Genet 2005. 14: 1549-1558.
46. Mattick, J. S. and Makunin, I. V., Small regulatory RNAs in mammals. Hum Mol Genet 2005. 14: R121-R132.
47. Xie, W., Ted, B. W. and Denman, R. B., Translational regulation by nonprotein-coding RNAs: different targets, common themes. Biochem Biophys Res Commun 2008. 373: 462-466.
48. He, L. and Hannon, G. J., MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004. 5: 522-531.
49. Bartel, D. P. and Chen, C. Z., Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004. 5: 396-400.
50. Sevignani, C., Calin, G. A., Siracusa, L. D. and Croce, C. M., Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 2006. 17: 189-202.
51. Lee, H. J., Palkovits, M. and Young, W. S., III, miR-7b, a microRNA upregulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation. Proc Natl Acad Sci USA 2006. 103: 15669-15674.
52. Zhu, S., Si, M. L., Wu, H. and Mo, Y. Y., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007. 282: 14328-14336.
53. Karres, J. S., Hilgers, V., Carrera, I., Treisman, J. and Cohen, S. M., The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 2007. 131: 136-145.
54. Visone, R., Russo, L., Pallante, P., De, M., Ferraro, A., et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007. 14: 791-798.
55. Jackson, R. J. and Standart, N., How do microRNAs regulate gene expression? Sci STKE 2007. 2007: re1.
56. Saetrom, P., Heale, B. S., Snove, O., Jr., Aagaard, L., Alluin, J., et al. Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res 2007. 35: 2333-2342.
57. Krek, A., Grun, D., Poy, M. N., Wolf, R., Rosenberg, L., et al. Combinatorial microRNA target predictions. Nat Genet 2005. 37: 495-500.
58. Hobert, O., Gene regulation by transcription factors and microRNAs. Science 2008. 319: 1785-1786.
59. Hobert, O., Common logic of transcription factor and microRNA action. Trends Biochem Sci 2004. 29: 462-468.
60. Hornstein, E. and Shomron, N., Canalization of development by micro-RNAs. Nat Genet 2006. 38: S20-S24.
61. John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., et al. Human MicroRNA targets. PLoS Biol 2004. 2: e363.
62. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. and Burge, C. B., Prediction of mammalian microRNA targets. Cell 2003. 115:
63. Rehmsmeier, M., Steften, P., Hoschsmann, M. and Glegerich, R., Fast and effective prediction of microRNA/target duplexes. RNA 2004. 10: 1507-1517.
64. Martin, G., Schouest, K., Kovvuru, P. and Spillane, C., Prediction and validation of microRNA targets in animal genomes. J Biosci 2007. 32: 1049-1052.
65. Hariharan, M., Scaria, V., Pillai, B. and Brahmachari, S. K., Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun 2005. 337: 1214-1218.
66. Fraser, H. B., Hirsh, A. E., Giaever, G., Kumm, J. and Eisen, M. B., Noise minimization in eukaryotic gene expression. PLoS Biol 2004. 2: e137.
67. Eisenberg, E. and Levanon, E. Y., Human housekeeping genes are compact. Trends Genet 2003. 19: 362-365.
68. Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L. and Bradley, A., Identification of mammalian microRNA host genes and transcription units. Genome Res 2004. 14: 1902-1910.
69. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003. 4: 3.
70. Stark, A., Brennecke, J., Bushati, N., Russell, R. B. and Cohen, S. M., Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 2005. 123: 1133-1146.
71. Liang, Y., Ridzon, D., Wong, L. and Chen, C., Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007. 8: 166.
72. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007. 129: 1401-1414.
73. Georges, M., Coppieters, W. and Charlier, C., Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 2007. 17: 166-176.
74. Martin, M. M., Buckenberger, J. A., Jiang, J., Malana, G. E., Nuovo, G. J., et al. The human angiotensin II type 1 receptor R1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 2007. 282: 24262-24269.
75. Iwai, N. and Naraba, H., Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 2005. 331: 1439-1444.
76. Hariharan, M., Scaria, V. and Brahmachari, S. K., dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 2009. 10: 108.
77. Griffiths-Jones, S., Grocock, R. J., Van DS, Bateman, A. and Enright, A. J., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006. 34: D140-D144.